Clinical Trials Browser

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT07606677 2026-05-26

Peripheral Blood CyTOF Immune Model for Cervical Lesion Detection in HPV16/18+ Women

Not yet recruiting

1,465 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT07520188 2026-05-19

CASCADE3002

Not yet recruiting

3,500 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT07593066 2026-05-18

PRIORITY

Not yet recruiting

700 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06519994 2026-05-14

Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya

Phase 2 Completed

120 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia

NCT07576842 2026-05-08

Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV

Phase NA Not yet recruiting

750 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT07454915 2026-05-06

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

Phase 2 Recruiting

138 enrolled

Gynecologic

Uterine Cervical Dysplasia

NCT07390916 2026-04-29

Feasibility Study Comparing One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 Rwanda

Phase NA Not yet recruiting

300 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia

NCT02328872 2026-04-17

Compass

Phase NA Active not recruiting

76,181 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT05051722 2026-04-17

ECHO

Recruiting

3,110 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Endometrial Hyperplasia, Ovarian Neoplasms, Endometrial Neoplasms

NCT05132114 2026-04-14

LLETZ-IOLI

Phase NA Completed

230 enrolled

Gynecologic

Uterine Cervical Dysplasia

NCT01989923 2026-04-07

Smoking Cessation in Women With Gynecological Conditions

Phase NA Completed

31 enrolled

Gynecologic

Vaping, Uterine Cervical Dysplasia, Smoking Cessation

NCT04226313 2026-03-23

KOPRETINA

Phase NA Recruiting

15,000 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06810427 2026-03-18

CervImage

Phase NA Active not recruiting

18 enrolled

Gynecologic

Uterine Cervical Dysplasia

NCT07468695 2026-03-12

Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS2 Kenya

Phase NA Not yet recruiting

300 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia

NCT07461818 2026-03-11

POC

Phase NA Recruiting

5,000 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT04712851 2026-03-10

Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia

Phase 2 Recruiting

25 enrolled

Gynecologic

Uterine Cervical Dysplasia

Clinical Trials

ASCEND

Peripheral Blood CyTOF Immune Model for Cervical Lesion Detection in HPV16/18+ Women

CASCADE3002

PRIORITY

Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya

Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

Feasibility Study Comparing One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 Rwanda

Compass

ECHO

LLETZ-IOLI

Smoking Cessation in Women With Gynecological Conditions

KOPRETINA

CervImage

Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS2 Kenya

POC

Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia